Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lifestyle and Environment Aspects Challenging Kidney Health.

Kidney & blood pressure research·2026
Same author

Lipoprotein apheresis as rescue therapy in lipoprotein glomerulopathy: The role of plasmatic extracellular vesicle removal.

Journal of clinical lipidology·2026
Same author

Editorial: Early diagnosis of kidney disease in young adulthood.

Frontiers in nephrology·2025
Same author

High-flux hemodialysis with polymethylmethacrylate membranes reduces soluble CD40L, a mediator of cardiovascular disease in uremia.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2025
Same author

Treatment Optimization and Standard of Care Adherence in CKD Primary Care: the TOSCA-CKD project.

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2025
Same author

Ketogenic diets in chronic kidney disease patients: a review for skeptics by skeptics.

Journal of nephrology·2025

Related Experiment Video

Updated: Jul 5, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

Inflammatory pattern in hemodiafiltration.

Vincenzo Panichi1, Sabrina Paoletti, Cristina Consani

  • 1Department of Internal Medicine, University of Pisa, Pisa, Italy.

Contributions to Nephrology
|May 3, 2008
PubMed
Summary

Chronic inflammation, indicated by C-reactive protein (CRP) and interleukin-6 (IL-6), predicts mortality in hemodialysis (HD) patients. High-efficiency hemodiafiltration (HDF) improves survival, independent of dialysis dose.

Area of Science:

  • Nephrology
  • Inflammation Biology
  • Clinical Medicine

Background:

  • Chronic inflammation is linked to increased morbidity and mortality in hemodialysis (HD) patients.
  • Elevated interleukin-6 (IL-6) and C-reactive protein (CRP) are associated with cardiovascular disease and low albumin (MIA syndrome).
  • Dialysis modality, membrane type, and dialysate quality may influence chronic inflammation in HD patients.

Purpose of the Study:

  • To investigate traditional and non-traditional risk factors for mortality and morbidity in HD patients.
  • To evaluate the impact of different HD modalities on patient outcomes.
  • To analyze the role of inflammation markers in predicting mortality within the HD population.

Main Methods:

  • Observational, prospective trial (RISCAVID study) of the entire chronic HD population in Northwest Tuscany.

Related Experiment Videos

Last Updated: Jul 5, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

  • 30-month follow-up data collection.
  • Analysis of risk factors, including inflammatory markers (CRP, IL-6), and HD modalities (HD vs. HDF).

    • Main Results:

    • Synergistic effect of CRP and pro-inflammatory cytokines identified as strong predictors of overall and cardiovascular mortality.
    • High-efficiency hemodiafiltration (HDF) demonstrated an association with improved cumulative survival.
    • This survival benefit from HDF was observed independently of the dialysis dose administered.

    Conclusions:

    • Inflammatory markers like CRP and IL-6 are critical predictors of mortality in hemodialysis patients.
    • High-efficiency hemodiafiltration (HDF) offers a survival advantage over standard hemodialysis (HD).
    • The benefits of HDF on survival are significant, irrespective of the delivered dialysis dose, highlighting its potential as a superior treatment modality.